Understanding the benefits of risk-based optimization on clinical trial supply planning

Amaury Jeandrain is an expert in Clinical trial supply and manufacturing optimization. He started his career in clinical supply chain working for a CMO before joining N-SIDE. In his 5 years of experience at N-SIDE, Amaury supported the optimization of hundreds of trials and programs from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the Adoption N-SIDE’s solutions.

Cyrille Lefèvre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 8 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Cyrille also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.